Israel’s Bank Leumi leads $150 million round in medtech fund ALIVE as an anchor investor
ALIVE will focus on mature companies in the fields of medical technology, medical equipment, and telemedicine and intends to lead 10-15 rounds of between $10 million and $30 million, within the next four years
The three other anchor investors in the fund, announced last year, are Maccabi Fund, which is associated with the Israeli health maintenance organization (HMO) Maccabi Healthcare Service, British-Iranian entrepreneur Vincent Tchenguiz, through his investment firm Consensus Business Group (CBG), and not-for-profit Virginia and West Virginia healthcare organization Carilion Clinics.
ALIVE will focus on mature companies in the fields of medical technology, medical equipment, and telemedicine and intends to lead 10-15 rounds of between $10 million and $30 million, within the next four years, the people said. The fund will invest between $5 million and $10 million in each company.
The fund intends to make its first investments in the upcoming weeks, the people said, and its first investment will be in a cardiology company.
Maccabi and Assuta will both have observers on ALIVE's board. The fund will be based at the Assuta Tower in northern Tel Aviv.
"ALIVE is the first fund that is built on the foundation of an active strategic relationship with private hospital chains and an HMO, which set out to provide high quality, cost-effective innovative medical services to patients,” Shamiss told Calcalist in an interview.